Enlaza and Vertex Partner on War-Lock Conjugates and T-Cell Engagers
Enlaza Therapeutics and Vertex Pharmaceuticals Forge Multi-Billion-Dollar Collaboration to Advance Next-Generation Covalent Biologics in Autoimmune Diseases and Conditioning Therapies Enlaza Therapeutics (“Enlaza” or the “Company”), a pioneering biotechnology firm and…
CapVest Set to Acquire Majority Ownership in STADA from Bain Capital and Cinven
CapVest to Acquire Majority Stake in STADA from Bain Capital and Cinven CapVest Partners LLP (“CapVest”), a global investment firm with a reputation for building essential businesses across healthcare, consumer,…
Daiichi Sankyo Begins Development of Oral Triple Combo Lipid-Lowering Tablets for LDL-C Management
Daiichi Sankyo Advances Cardiovascular Care with Development of Oral Triple Combination Lipid-Lowering Tablets A New Chapter in Cholesterol Management Daiichi Sankyo Europe has unveiled an ambitious new initiative: the development…
Alnylam Moves Zilebesiran into Global Phase 3 Trial
Alnylam Advances Zilebesiran Into Global Phase 3 Cardiovascular Outcomes Trial Following Promising Phase 2 KARDIA Results Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), a recognized leader in RNA interference (RNAi) therapeutics, announced…
Bristol Myers Squibb Showcases Global Real-World Data on Camzyos at ESC 2025
Bristol Myers Squibb Showcases Landmark Real-World Data on Camzyos in Obstructive Hypertrophic Cardiomyopathy at ESC Congress 2025 Bristol Myers Squibb (NYSE: BMY) unveiled new results from its global COLLIGO-HCM study…
BeOne Reports Positive Results for Sonrotoclax in MCL
BeOne Medicines Announces Positive Topline Results from Phase 1/2 Study of Sonrotoclax in Relapsed or Refractory Mantle Cell Lymphoma BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global…
TechImmune Names James F. Young, Ph.D. as Executive Chairman
James F. Young, Ph.D. Appointed Executive Chairman of TechImmune, Bringing Four Decades of Vaccine Innovation and Leadership to the Fight Against Long COVID TechImmune, a biotechnology company at the forefront…
Ostro Unveils Airmark to Evolve Pharma Email Marketing with Compliant Conversational AI
Ostro Unveils Airmark to Transform Static Pharma Emails into Dynamic, Compliant Conversational AI Ostro, an AI-powered engagement platform already trusted by more than half of the top 20 global pharmaceutical…
Walgreens to Become Private Standalone Firm After Sycamore Partners Acquisition
Walgreens Embarks on New Era as Private Standalone Company Following Acquisition by Sycamore Partners Walgreen Co. (“Walgreens” or “the Company”), one of America’s most iconic retail pharmacy chains and a…
Thermo Fisher Wins R&D 100 Awards for Breakthrough Therapy Innovations
Thermo Fisher Scientific Honored with Three R&D 100 Awards for Innovations Transforming Precision Medicine, Cell Therapy, and Biopharmaceutical Research Thermo Fisher Scientific Inc. (NYSE: TMO), the global leader in serving…
Enveric Completes Pre-IND Studies for Lead Candidate EB-003
Enveric Biosciences Advances Neuropsychiatric Pipeline with Successful Completion of Dose Range Finding Studies for Lead Candidate EB-003 Enveric Biosciences, Inc. (NASDAQ: ENVB), a biotechnology company pioneering next-generation neuroplastogenic small-molecule therapeutics,…
Hope Biosciences Earns FDA RMAT for MS Stem Cell Therapy
Hope Biosciences Receives FDA RMAT Designation for Stem Cell Therapy in Relapsing-Remitting Multiple Sclerosis Hope Biosciences, a leading U.S.-based stem cell banking and cellular therapeutics manufacturer, has announced a major…